conv.

← The whole story
Business
Novo Nordisk shares plunge 7% as 2030 growth plan disappoints investors

Novo Nordisk announces 2030 growth targets at capital markets day in London

The Danish pharmaceutical company outlined a long-term strategy including plans to launch more than five blockbuster drugs by 2030, achieve compound annual revenue growth in line with industry peers through 2030 while maintaining stable operating margins, and expand manufacturing to make oral GLP-1 treatments available to 10 times as many people with obesity. The company also expects its risk-adjusted pipeline to generate more than DKK 150 billion in sales by 2035.

Novo Nordisk announces 2030 growth targets at capital markets day in London
Yahoo Finance

Novo Nordisk Danish pharmaceutical companyMike DoustdarMike Doustdar Novo Nordisk Chief Executive OfficerEli Lilly & Co. Rival pharmaceutical company

The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump

Peak 5 pieces in two hours at Sep 21, 5 AM; 16 pieces over 7 days (15 articles · 1 post) Sep 21, 3 AM — 4 pieces · 4 articles — Newswires 4Sep 21, 5 AM — 5 pieces · 4 articles · 1 post — Newswires 4, Mastodon 1Sep 21, 7 AM — 2 pieces · 2 articles — Newswires 2Sep 21, 9 AM — 2 pieces · 2 articles — Newswires 2Sep 21, 11 AM — 1 piece · 1 article — Newswires 1Sep 21, 1 PM — quietSep 21, 3 PM — quietSep 21, 5 PM — quietSep 21, 7 PM — quietSep 21, 9 PM — quietSep 21, 11 PM — quietSep 22, 1 AM — quietSep 22, 3 AM — 1 piece · 1 article — Google News 1Sep 22, 5 AM — 1 piece · 1 article — Google News 1Sep 22, 7 AM — quietSep 22, 9 AM — quietSep 22, 11 AM — quietSep 22, 1 PM — quietSep 22, 3 PM — quietSep 22, 5 PM — quietSep 22, 7 PM — quietSep 22, 9 PM — quietSep 22, 11 PM — quietSep 23, 1 AM — quietSep 23, 3 AM — quietSep 23, 5 AM — quietSep 23, 7 AM — quietSep 23, 9 AM — quietSep 23, 11 AM — quietSep 23, 1 PM — quietSep 23, 3 PM — quietSep 23, 5 PM — quietSep 23, 7 PM — quietSep 23, 9 PM — quietSep 23, 11 PM — quietSep 24, 1 AM — quietSep 24, 3 AM — quietSep 24, 5 AM — quietSep 24, 7 AM — quietSep 24, 9 AM — quietSep 24, 11 AM — quietSep 24, 1 PM — quietSep 24, 3 PM — quietSep 24, 5 PM — quietSep 24, 7 PM — quietSep 24, 9 PM — quietSep 24, 11 PM — quietSep 25, 1 AM — quietSep 25, 3 AM — quietSep 25, 5 AM — quietSep 25, 7 AM — quietSep 25, 9 AM — quietSep 25, 11 AM — quietSep 25, 1 PM — quietSep 25, 3 PM — quietSep 25, 5 PM — quietSep 25, 7 PM — quietSep 25, 9 PM — quietSep 25, 11 PM — quietYesterday, 1 AM — quietYesterday, 3 AM — quietYesterday, 5 AM — quietYesterday, 7 AM — quietYesterday, 9 AM — quietYesterday, 11 AM — quietYesterday, 1 PM — quietYesterday, 3 PM — quietYesterday, 5 PM — quietYesterday, 7 PM — quietYesterday, 9 PM — quietYesterday, 11 PM — quietToday, 1 AM — quietToday, 3 AM — quietToday, 5 AM — quietToday, 7 AM — quietToday, 9 AM — quietToday, 11 AM — quietToday, 1 PM — quietToday, 3 PM — quiet 1–5
Sep 22Sep 23Sep 24Sep 25yesterdaynow · 4:56 PM ET

What was reported 2 claims about this development

  1. first by Yahoo Finance, 6d ago · also Quartz, Investing.com News

    3 more headlines
  2. first by Investing.com News, 6d ago

All 5 developments of Novo Nordisk shares plunge 7% as 2030 growth plan… →

NewswiresMastodonGoogle News